The Motley Fool” with a publish date: April 02, 2018, “XBiotech: Strong Upside Potential In Atopic Dermatitis And Hidradenitis Suppurativa – Seeking …
Source link
Related
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
0
0
Steve
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
Steve2019-02-15 07:42:082019-02-15 07:42:08AnaptysBio, Inc. (ANAB) EPS Estimated At $-0.91 as of March, 4
Leave a Reply
Want to join the discussion?Feel free to contribute!